News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
685,536 Results
Type
Article (39047)
Company Profile (279)
Press Release (646210)
Section
Business (203875)
Career Advice (1988)
Deals (35370)
Drug Delivery (85)
Drug Development (80801)
Employer Resources (168)
FDA (16086)
Job Trends (14805)
News (344562)
Policy (32438)
Tag
Academia (2531)
Alliances (49082)
Alzheimer's disease (1228)
Approvals (16018)
Artificial intelligence (130)
Bankruptcy (352)
Best Places to Work (11535)
Biotechnology (200)
Breast cancer (119)
Cancer (1077)
Cardiovascular disease (97)
Career advice (1658)
Cell therapy (231)
Clinical research (64233)
Collaboration (384)
Compensation (197)
COVID-19 (2530)
C-suite (94)
Data (1119)
Diabetes (152)
Diagnostics (6139)
Earnings (84816)
Employer resources (146)
Events (109454)
Executive appointments (307)
FDA (16616)
Funding (346)
Gene therapy (176)
GLP-1 (574)
Government (4324)
Healthcare (18669)
Infectious disease (2614)
Inflammatory bowel disease (106)
Interviews (308)
IPO (16295)
Job creations (3624)
Job search strategy (1416)
Layoffs (412)
Legal (7853)
Lung cancer (170)
Manufacturing (176)
Medical device (13175)
Medtech (13180)
Mergers & acquisitions (19146)
Metabolic disorders (398)
Neuroscience (1503)
NextGen Class of 2024 (6499)
Non-profit (4464)
Northern California (1474)
Obesity (228)
Opinion (179)
Patents (101)
People (56265)
Phase I (19948)
Phase II (28293)
Phase III (21094)
Pipeline (454)
Postmarket research (2553)
Preclinical (8488)
Radiopharmaceuticals (235)
Rare diseases (217)
Real estate (5894)
Regulatory (21518)
Research institute (2308)
Resumes & cover letters (349)
Southern California (1297)
Startups (3561)
United States (13376)
Vaccines (548)
Weight loss (166)
Date
Today (132)
Last 7 days (786)
Last 30 days (3731)
Last 365 days (35590)
2024 (32589)
2023 (40074)
2022 (51176)
2021 (55715)
2020 (54090)
2019 (46544)
2018 (35021)
2017 (32114)
2016 (31484)
2015 (37555)
2014 (31320)
2013 (26351)
2012 (28576)
2011 (29267)
2010 (27330)
Location
Africa (713)
Arizona (192)
Asia (37119)
Australia (6059)
California (3307)
Canada (1282)
China (247)
Colorado (143)
Connecticut (150)
Europe (79501)
Florida (455)
Georgia (116)
Illinois (338)
Indiana (195)
Kansas (96)
Maryland (573)
Massachusetts (2587)
Michigan (157)
Minnesota (271)
New Jersey (947)
New York (949)
North Carolina (696)
Northern California (1474)
Ohio (138)
Pennsylvania (839)
South America (1091)
Southern California (1297)
Texas (458)
Utah (90)
Washington State (357)
685,536 Results for "paragon bioservices inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Paragon 28 to Present at the Bank of America Securities 2024 Healthcare Conference
Paragon 28, Inc. announced that Albert DaCosta, Chairman and CEO, and Krissy Wright, Interim CFO, will participate in a fireside chat at the Bank of America Securities 2024 Healthcare Conference on Tuesday, May 14, 2024, at 5:00 p.m. Pacific Time / 6:00 p.m. Mountain Time.
May 2, 2024
·
1 min read
Deals
Elevance Health Announces Closing of Paragon Healthcare Acquisition
Elevance Health announced the closing of its acquisition of Paragon Healthcare, Inc., a company specializing in life-saving and life-giving infusible and injectable therapies.
March 11, 2024
·
6 min read
Business
Paragon 28 Reports First Quarter 2024 Financial Results and Reaffirms 2024 Net Revenue Guidance
Paragon 28, Inc., a leading medical device company exclusively focused on the foot and ankle orthopedic market, reported financial results for the quarter ended March 31, 2024, and reaffirmed its 2024 net revenue guidance.
May 8, 2024
·
12 min read
Deals
Elevance Health to Acquire Paragon Healthcare
Elevance Health announced that it has entered into an agreement to acquire Paragon Healthcare, Inc., a company specializing in life-saving and life-giving infusible and injectable therapies.
January 4, 2024
·
7 min read
Biotech Beach
Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance
Avid Bioservices, Inc. announced that the company has achieved a Committed Badge from EcoVadis, one of the world’s most trusted providers of business sustainability ratings.
May 23, 2024
·
2 min read
BioMidwest
Paragon 28 Adds to Suite of Novel Syndesmosis Repair Solutions with Launch of Grappler® R3INFORCE™ Extraosseous Repair System
Paragon 28, Inc., is pleased to announce the launch of the Grappler® R3INFORCE™ Extraosseous Repair System designed to restore stability to the anterior and posterior ligaments surrounding the ankle during fibula fracture repairs and high ankle sprains.
March 28, 2024
·
5 min read
Deals
Paragon Therapeutics Announces Oruka Therapeutics Has Entered into Merger Agreement with ARCA biopharma to Advance Novel Treatments for Chronic Skin Diseases
Paragon Therapeutics announced today that the third company founded based on assets generated by Paragon, Oruka Therapeutics (“Oruka”), has entered into a definitive agreement with ARCA biopharma to combine the companies in an all-stock transaction.
April 3, 2024
·
3 min read
Business
Paragon 28 To Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024
Paragon 28, Inc. announced it will report financial results for the fourth quarter and full year 2023 after market close on Thursday, February 29, 2024.
February 6, 2024
·
1 min read
Business
Paragon 28 Announces CFO Transition, Provides Preliminary Unaudited Net Revenue for First Quarter 2024, and Reaffirms Net Revenue Guidance for Fiscal Year 2024
Paragon 28, Inc. announced that Stephen Deitsch, Chief Financial Officer, has notified the Company of his intent to pursue an opportunity with OrganOx Limited, a commercial stage UK-based medical device company focused on therapeutic applications of isolated organ perfusion.
April 4, 2024
·
7 min read
Biotech Beach
Avid Bioservices to Participate at Upcoming May 2024 Investor Conferences
Avid Bioservices, Inc., a dedicated biologics contract development and manufacturing organization working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, announced that the company will participate at two upcoming investor conferences.
May 7, 2024
·
1 min read
1 of 68,554
Next
